News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Scientists discover how some advanced breast cancers become resistant to hormone therapy

07/02/24

New research has identified why some advanced oestrogen receptor (ER) positive breast cancers become resistant to hormone therapy, and has identified drugs currently in development that could keep disease stable for longer for these patients.
An artist's impression of The London Cancer Hub
ICR welcomes appointment of Aviva and Socius for new life-sciences development at The London Cancer Hub

22/01/24

The Institute of Cancer Research has welcomed the appointment of a new partnership to deliver a major redevelopment project at The London Cancer Hub in Sutton.
breast cancer cell
ICR welcomes recommendation of talazoparib for advanced breast cancer

19/01/24

The Institute of Cancer Research, London, strongly welcomes the news that talazoparib (trade name Talzenna) has been recommended by NICE for the treatment of advanced breast cancer.
ICR Logo
We must not rush to implement new genetic screening programmes, experts warn

15/01/24

There is a danger that population genetic screening programmes may be introduced without the necessary scrutiny and rigour that is usually applied when screening programmes are put into effect, experts have warned.
Prostate Cancer Cells 547x411px
Scientists now able to predict response to radium-223 treatment in prostate cancer bone metastases

21/12/23

Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones.
Professor Clare Isacke in the ICR lab
Professor Clare Isacke wins prestigious award for women in science

19/12/23

Professor Clare Isacke has been awarded the biennial Women in Science Achievement Award by the Metastasis Research Society (MRS).
Breast cancer organoid
New understanding of devastating type of breast cancer spread could lead to better treatments

14/12/23

A new study has increased the understanding of an increasingly common complication of advanced breast cancer.
A woman walks her dog in autumn. Trees line the path.
Largest study of its kind suggests physical activity reduces a woman’s risk of developing breast cancer before menopause

11/12/23

Regular leisure time physical activity may reduce the risk of breast cancer for women before menopause, according to new research funded by Breast Cancer Now.
ICR Logo
Star-studded Carols from Chelsea kicks off Christmas season in style

07/12/23

Famous faces and guests packed the stunning Wren Chapel at the Royal Hospital Chelsea, for the 21st year of Carols from Chelsea, in support of our world-leading research.
Collage of nine science images of cells, structures and equipment
Scientific achievements of 2023

05/12/23

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research.
ICR Logo
Trial results support ‘new gold standard’ for head and neck cancer radiotherapy

22/11/23

Phase 3 trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after radiotherapy, without impacting the success of treatment.
Lou Chesler 547x410
Major collaborative childhood cancer research programme launched with £5.5 million funding from Children with Cancer UK and Cancer Research UK

20/11/23

Leading charities Children with Cancer UK and Cancer Research UK come together to co-fund a second cancer research programme aiming to help treat relapsed childhood cancers through precision medicine. The SMPaeds2 project will be led by Professor Louis Chesler at The Institute of Cancer Research, London.


Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.